Compare GDOT & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GDOT | PACB |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.2M | 655.9M |
| IPO Year | 2010 | 2010 |
| Metric | GDOT | PACB |
|---|---|---|
| Price | $12.22 | $2.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $16.13 | $2.54 |
| AVG Volume (30 Days) | 294.4K | ★ 15.4M |
| Earning Date | 11-17-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $2,080,491,000.00 | $93,468,000.00 |
| Revenue This Year | $15.22 | N/A |
| Revenue Next Year | $6.73 | $16.01 |
| P/E Ratio | $37.18 | ★ N/A |
| Revenue Growth | ★ 20.69 | 3.04 |
| 52 Week Low | $10.10 | $1.07 |
| 52 Week High | $13.75 | $3.44 |
| Indicator | GDOT | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 54.13 |
| Support Level | $11.95 | $1.24 |
| Resistance Level | $12.66 | $3.44 |
| Average True Range (ATR) | 0.23 | 0.26 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 38.33 | 47.25 |
Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for todays workforce.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.